Study design is a crucial compound of the clinical trial. If a study is not well controlled or the appropriate study population is not chosen, it might not be possible to identify efficaciousness of an adjuvant for a reduction of postoperative adhesions. There is probably no one protocol that is most appropriate for all adjuvants; protocols must be individualized based on unique characteristics of the products and the manner in which they are to be used.
|Original language||English (US)|
|Number of pages||4|
|Journal||Infertility and Reproductive Medicine Clinics of North America|
|State||Published - Jul 2003|
ASJC Scopus subject areas
- Obstetrics and Gynecology